{
  "eval_id": "S23",
  "eval_file": "evals/single/S23.json",
  "timestamp": "2025-09-18T16:40:27.674719Z",
  "model": "gpt-4.1",
  "temperature": 0.6,
  "rep_input": "Patient HR+/HER2- progressed after CDK4/6; what key label-based caveats should I discuss?",
  "model_output": "For HR+/HER2- patients who progressed after CDK4/6, next steps depend on prior endocrine and chemo exposure, performance status, and comorbidities. Please send the SmPC or EMA summary for the product you’re referring to, and I’ll check key label caveats specific to that therapy."
}